Bruce Rashbaum

1.1k citations
14 papers · 975 · 1 hit paper · h-index 10

Impact in

Papers in

    • HIV Research and Treatment 7
    • HIV/AIDS drug development and treatment 12
    • HIV/AIDS Research and Interventions 5

Bruce Rashbaum

14 papers receiving 949 citations

Bruce Rashbaum's Hit Papers

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1 2015 · 354 citations
3540+3+7Years since publication100200300

Peers

Bruce Rashbaum
Comparison fields: 5 of 53
  • Hepatology 369
  • Virology 208
  • Infectious Diseases 518
  • Emergency Medicine 177
  • Epidemiology 263
Replace Hernan Valdez with:
Hernan Valdez United States
Laveeza Bhatti United States
Pilar García‐Gascó Spain
G. Gaspar Spain
Marcello H. Losso Argentina
Will Garner United States
Herminia Esteban Spain
Guenter Dollenmaier Switzerland
Melissa Shaughnessy United States
Corklin R. Steinhart United States
Bruce Rashbaum relative to Hernan Valdez United States Hernan Valdez's profile →
Citations per field
00.5×5×10×15×20×24×
Hernan Valdez · 1×
Citations per year

Countries citing papers authored by Bruce Rashbaum

Since Specialization
Citations

This map shows the geographic impact of Bruce Rashbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Rashbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Rashbaum more than expected).

Fields of papers citing papers by Bruce Rashbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Rashbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Rashbaum. The network helps show where Bruce Rashbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce Rashbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce Rashbaum Line = papers co-authored together Bruce Rashbaum links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Hit paper breakdown →
2015354
2 2016167
3 201199
4 201781
5 200076
6 202171
7 201845
8 201933
9 201418
10 201911
11 20059
12 20115
13 20195
14 20171

About Bruce Rashbaum

Bruce Rashbaum is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Genetics, having authored 14 papers that have together received 975 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers), HIV-related health complications and treatments (2 papers), Hepatitis C virus research (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Hepatology (369 citations), Virology (208 citations), Infectious Diseases (518 citations), Emergency Medicine (177 citations) and Epidemiology (263 citations). Bruce Rashbaum has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Cynthia Brinson, Andrew Cheng, Cristina Mussini, Calvin J. Cohen, Nathan Clumeck, Peter Jerome Ruane, Shinichi Oka, Marshall W. Fordyce, Jeffrey L. Stephens and Karen T. Tashima. Their work appears in journals such as HIV Clinical Trials, The Lancet HIV, AIDS Research and Human Retroviruses, AIDS and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact